OUR TECHnology

Our platform is uniquely able to target multiple misfolded protein aggregates implicated in serious diseases

AN URGENT NEED

Learn about our approach to meet the dire need for new treatments for neurodegenerative diseases

LATEST NEWS

Proclara Biosciences Presents New Preclinical Data Supporting Development of GAIM-Based Therapies at Society for Neuroscience Annual Meeting